Business · 19/12/2012Updated: 10/17/2026 · 1 min read
FDA to Hold Public Hearing on Impact of Approved Drug Labeling on Chronic Opioid Therapy
Summary
The FDA is seeking public input on the use of opioid drugs in treating chronic pain, following the approval of new labeling requirements, and will hold a public hearing to gather scientific evidence and data.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →